FITCHBURG, MA--(Marketwire - May 17, 2012) - Arrhythmia Research Technology, Inc. (the "Company") (NYSE MKT: HRT) (NYSE Amex: HRT) and its subsidiaries reported total revenue of $6,305,000 and net loss of $375,000 for the three months ended March 31, 2012 compared to total revenue of $6,183,000 and net income of $27,000 for the same quarter of 2011. Net loss per share for the three months ended March 31, 2012 was $0.13 per share compared to $0.01 in earnings per share for the same period in 2011.